GT Biopharma, Inc. (GTBP) › Total AssetsGT Biopharma, Inc. (GTBP) — Total AssetsAnnual figures by period end, from SEC filings.2010-12-31: $185.0K2011-12-31: $129.0K2012-12-31: $226.0K2013-12-31: $147.0K2014-12-31: $888.0K2015-12-31: $54.0K2016-12-31: $25.0K2017-12-31: $254.37M2018-12-31: $25.40M2019-12-31: $396.0K2020-12-31: $5.66M2021-12-31: $32.17M2022-12-31: $16.74M2023-12-31: $14.11M2024-12-31: $4.23M2025-06-30: $7.12M2025-09-30: $4.32M2025-12-31: $8.11M$8.11M2010-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$8.11M—2026-03-02Balance as of period end2025-09-30$4.32M—2026-03-02Balance as of period end2025-06-30$7.12M—2026-03-02Balance as of period end2024-12-31$4.23M-70.0%2026-03-02Balance as of period end2023-12-31$14.11M-15.7%2025-02-21Balance as of period end2022-12-31$16.74M-48.0%2024-03-26Balance as of period end2021-12-31$32.17M+468.3%2023-03-30Balance as of period end2020-12-31$5.66M+1329.5%2021-04-16Balance as of period end2019-12-31$396.0K-98.4%2021-04-16Balance as of period end2018-12-31$25.40M-90.0%2020-03-27Balance as of period end2017-12-31$254.37M+1017372.0%2019-03-29Balance as of period end2016-12-31$25.0K-53.7%2018-03-01Balance as of period end2015-12-31$54.0K-93.9%2018-02-28Balance as of period end2014-12-31$888.0K+504.1%2018-02-28Balance as of period end2013-12-31$147.0K-35.0%2015-03-31Balance as of period end2012-12-31$226.0K+75.2%2015-01-08Balance as of period end2011-12-31$129.0K-30.3%2014-11-18Balance as of period end2010-12-31$185.0K—2012-04-16Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)